Eisenbarth George S, Moriyama Hiroaki, Robles David T, Liu Edwin, Yu Liping, Babu Sunanda, Redondo Maria J, Gottlieb Peter, Wegmann Dale, Rewers Marian
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Avenue, B-140, Denver, CO 80262, USA.
Autoimmun Rev. 2002 May;1(3):139-45. doi: 10.1016/s1568-9972(02)00035-6.
Type 1 diabetes of both the NOD mouse and man is associated with autoimmunity directed against insulin which is the only beta cell specific autoantigen identified to date. One can use autoantibodies to insulin to predict diabetes, use insulin peptides to create insulin autoantibodies, insulitis and diabetes, and use insulin or its peptides in animal models to prevent diabetes. An expanding set of resources are now available for the development and testing in man of therapies to prevent type 1 diabetes, and a number of trials utilizing insulin peptides are now underway.
非肥胖糖尿病(NOD)小鼠和人类的1型糖尿病都与针对胰岛素的自身免疫有关,胰岛素是迄今为止唯一被确定的β细胞特异性自身抗原。人们可以使用胰岛素自身抗体来预测糖尿病,使用胰岛素肽来产生胰岛素自身抗体、胰岛炎和糖尿病,以及在动物模型中使用胰岛素或其肽来预防糖尿病。现在有越来越多的资源可用于开发和测试预防1型糖尿病的疗法,并且一些利用胰岛素肽的试验正在进行中。